Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Biotechnology - Page 86

Biotechnology

Sorrento announced agreement to acquire SmartPharm and develop gene-encoded therapeutic antibodies for COVID-19 and cancer therapeutics
Biotechnology | COVID-19 | Therapeutics | Vaccine

Sorrento announced agreement to acquire SmartPharm and develop gene-encoded therapeutic antibodies for COVID-19 and cancer therapeutics

On Aug. 20, 2020, Sorrento Therapeutics and SmartPharm Therapeutics announced  the signing of a merger agreement under which…

Read More Sorrento announced agreement to acquire SmartPharm and develop gene-encoded therapeutic antibodies for COVID-19 and cancer therapeuticsContinue

La Jolla Institute for Immunology awarded $6.4 million for international efforts to beat COVID-19
Biotechnology | COVID-19 | Disease | Medicine | NIH | Therapeutics

La Jolla Institute for Immunology awarded $6.4 million for international efforts to beat COVID-19

On Aug. 20, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes…

Read More La Jolla Institute for Immunology awarded $6.4 million for international efforts to beat COVID-19Continue

Sorrento announced FDA IND filing for COVI-GUARD neutralizing and high potency antibody against SARS-CoV-2
Biotechnology | COVID-19 | Infectious Disease | Non-Profit Research

Sorrento announced FDA IND filing for COVI-GUARD neutralizing and high potency antibody against SARS-CoV-2

On Aug. 19, 2020, Sorrento announced that it had filed an investigational new drug application (IND) for COVI-GUARD…

Read More Sorrento announced FDA IND filing for COVI-GUARD neutralizing and high potency antibody against SARS-CoV-2Continue

Quidel update point-of-care Sofia SARS Antigen Test for COVID-19 to include either nasal or nasopharyngeal swabs
Biotechnology | COVID-19 | Life Science History

Quidel update point-of-care Sofia SARS Antigen Test for COVID-19 to include either nasal or nasopharyngeal swabs

On Aug. 19, 2020, Quidel announced that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofiaᆴ SARS…

Read More Quidel update point-of-care Sofia SARS Antigen Test for COVID-19 to include either nasal or nasopharyngeal swabsContinue

Experimental COVID-19 vaccine prevented severe disease in mice
Biotechnology | COVID-19 | Vaccine

Experimental COVID-19 vaccine prevented severe disease in mice

On Aug. 19, 2020, an experimental vaccine was reported to be effective at preventing pneumonia in mice infected…

Read More Experimental COVID-19 vaccine prevented severe disease in miceContinue

UT Southwestern announced open enrollment for at-home COLCORONA clinical trial
Biotechnology | COVID-19 | Infectious Disease

UT Southwestern announced open enrollment for at-home COLCORONA clinical trial

On Aug. 19, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced what is expected…

Read More UT Southwestern announced open enrollment for at-home COLCORONA clinical trialContinue

Atossa Therapeutics announced enrollment and dosing completed in clinical study of AT-301 COVID-19 nasal spray
Biotechnology | COVID-19

Atossa Therapeutics announced enrollment and dosing completed in clinical study of AT-301 COVID-19 nasal spray

On Aug. 17, 2020, Atossa Therapeutics announced that it had enrolled and dosed the first cohort of healthy…

Read More Atossa Therapeutics announced enrollment and dosing completed in clinical study of AT-301 COVID-19 nasal sprayContinue

Costa Rica announced horse antibodies for trials as an inexpensive COVID-19 therapy
Biotechnology | Therapeutics

Costa Rica announced horse antibodies for trials as an inexpensive COVID-19 therapy

On Aug. 17, 2020, Scientisfic American reported that Costa Rican scientists at the Clodomiro Picado Institute have inoculated…

Read More Costa Rica announced horse antibodies for trials as an inexpensive COVID-19 therapyContinue

FDA approved teatment for rare disease affecting optic nerves, spinal cord
Biotechnology | FDA | Neurology

FDA approved teatment for rare disease affecting optic nerves, spinal cord

On Aug. 17, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Enspryng (satralizumab-mwge) for the treatment…

Read More FDA approved teatment for rare disease affecting optic nerves, spinal cordContinue

Novavax initiated efficacy trial of COVID-19 vaccine in South Africa
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax initiated efficacy trial of COVID-19 vaccine in South Africa

On Aug. 17, 2020, Novavax announced the beginning of a Phase 2b clinical trial in South Africa to…

Read More Novavax initiated efficacy trial of COVID-19 vaccine in South AfricaContinue

Sanofi acquired Principia Biopharma for $3.68 billion
Biotechnology | Pharmaceutical

Sanofi acquired Principia Biopharma for $3.68 billion

On Aug. 17, 2020, Sanofi and Principia Biopharma announced a definitive agreement under which Sanofi will acquire all…

Read More Sanofi acquired Principia Biopharma for $3.68 billionContinue

XBiotech announced COVID-19 candidate therapy
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

XBiotech announced COVID-19 candidate therapy

On Aug. 17, 2020, XBiotech announced that it had identified True Human antibodies that could potentially be used…

Read More XBiotech announced COVID-19 candidate therapyContinue

NIH-supported research demonstrates how genetic variations cause eczema
Biotechnology | Disease | Non-Profit Research | Therapeutics

NIH-supported research demonstrates how genetic variations cause eczema

On Aug. 14, 2020, research supported by the National Institutes of Health delineated how two relatively common variations…

Read More NIH-supported research demonstrates how genetic variations cause eczemaContinue

Vaccine refusal and measles outbreaks increased in the U.S.
Biotechnology | Diagnostics | Infectious Disease | Measles | Vaccine

Vaccine refusal and measles outbreaks increased in the U.S.

On Aug. 14, 2020, in the U.S., despite high rates of coverage (>90%) at the national level for…

Read More Vaccine refusal and measles outbreaks increased in the U.S.Continue

Medigen Vaccines announced positive results of preclinical data for vaccine candidate against COVID-19
Biotechnology | COVID-19 | Therapeutics | Vaccine

Medigen Vaccines announced positive results of preclinical data for vaccine candidate against COVID-19

On Aug. 14, 2020, Medigen Vaccine Biologics (MBV) published preclinical results of their COVID-19 vaccine candidate in BioRxiv,…

Read More Medigen Vaccines announced positive results of preclinical data for vaccine candidate against COVID-19Continue

Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidate
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidate

On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…

Read More Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidateContinue

ADHD risk may be linked to inflammation during pregnancy
Biotechnology | Diagnostics | Disease | Neurology | Therapeutics | Women's Health

ADHD risk may be linked to inflammation during pregnancy

On Aug. 13, 2020, in a first-of-its-kind study in humans, investigators at the Center for ADHD Research at…

Read More ADHD risk may be linked to inflammation during pregnancyContinue

Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidate
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidate

On Aug. 13, 2020, Novavax and SK bioscience announced a development and supply agreement for the antigen component…

Read More Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidateContinue

Celdara Medical announced receipt of NIH funding for pandemic influenza antiviral development
Biotechnology | COVID-19 | Influenza | NIH

Celdara Medical announced receipt of NIH funding for pandemic influenza antiviral development

On Aug. 12, 2020, Celdara Medical announced that the NIH had awarded a Small Business Innovation Research (SBIR)…

Read More Celdara Medical announced receipt of NIH funding for pandemic influenza antiviral developmentContinue

China National Medical Products Administration approved Truvada for HIV pre-exposure prophylaxis
Biotechnology | HIV | Infectious Disease | Medicine | Therapeutics | Vaccine | WHO

China National Medical Products Administration approved Truvada for HIV pre-exposure prophylaxis

On Aug. 11, 2020, Gilead Sciences announced that the China National Medical Products Administration (NMPA) had approved a…

Read More China National Medical Products Administration approved Truvada for HIV pre-exposure prophylaxisContinue

Moderna announced supply agreement with U.S. Government for initial 100 million doses of mRNA vaccine against COVID-19
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced supply agreement with U.S. Government for initial 100 million doses of mRNA vaccine against COVID-19

On Aug. 11, 2020, Moderna announced that the U.S. government had secured 100 million doses of mRNA-1273. The…

Read More Moderna announced supply agreement with U.S. Government for initial 100 million doses of mRNA vaccine against COVID-19Continue

FDA approved oral treatment for spinal muscular atrophy
Biotechnology | Disease | FDA | Therapeutics

FDA approved oral treatment for spinal muscular atrophy

On Aug. 7, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Evrysdi (risdiplam) to treat patients…

Read More FDA approved oral treatment for spinal muscular atrophyContinue

Scientists revealed structural details of spike protein used in leading COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Scientists revealed structural details of spike protein used in leading COVID-19 vaccine

On Aug. 7, 2020, scientists at Scripps Research announced they had obtained high-resolution, atomic-scale details of the structure…

Read More Scientists revealed structural details of spike protein used in leading COVID-19 vaccineContinue

Altimmune Completed enrollment in phase 1b clinical trial of NasoShield, a single dose intranasal anthrax vaccine candidate
Biotechnology | Vaccine

Altimmune Completed enrollment in phase 1b clinical trial of NasoShield, a single dose intranasal anthrax vaccine candidate

On Aug. 7, 2020, Altimmune announced that it had completed enrollment in its Phase 1b clinical trial of…

Read More Altimmune Completed enrollment in phase 1b clinical trial of NasoShield, a single dose intranasal anthrax vaccine candidateContinue

Novavax and Takeda announced collaboration for Novavax COVID-19 vaccine candidate in Japan
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Pharmaceutical | Vaccine

Novavax and Takeda announced collaboration for Novavax COVID-19 vaccine candidate in Japan

On Aug. 7, 2020, Novavax and Takeda Pharmaceutical announced a partnership for the development, manufacturing and commercialization of…

Read More Novavax and Takeda announced collaboration for Novavax COVID-19 vaccine candidate in JapanContinue

RedHill Biopharma’s phase 2/3 COVID-19 study approved in Mexico
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics

RedHill Biopharma’s phase 2/3 COVID-19 study approved in Mexico

On Aug. 6, 2020, RedHill Biopharma announced approval from the Mexican Federal Committee for the Protection against Sanitary…

Read More RedHill Biopharma’s phase 2/3 COVID-19 study approved in MexicoContinue

Novavax signed COVID-19 vaccine supply deal with India’s Serum Institute
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Therapeutics | Vaccine

Novavax signed COVID-19 vaccine supply deal with India’s Serum Institute

On Aug. 6, 2020, Novavax announced it had entered a supply and license agreement with the Serum Institute…

Read More Novavax signed COVID-19 vaccine supply deal with India’s Serum InstituteContinue

First clone of endangered Przewalski’s horse born in conservation effort to save the species
Biotechnology | Cloning | Veterinary

First clone of endangered Przewalski’s horse born in conservation effort to save the species

On Aug. 6, 2020, the world’s first successfully cloned endangered Przewalski’s horse was born. Revive & Restore, San…

Read More First clone of endangered Przewalski’s horse born in conservation effort to save the speciesContinue

Rapid diagnostic for gonorrhea won $19 million federal prize competition to combat antibiotic resistance
Biotechnology | Diagnostics

Rapid diagnostic for gonorrhea won $19 million federal prize competition to combat antibiotic resistance

On Aug. 5, 2020, a diagnostic test capable of accurately and reliably detecting the microorganism that causes gonorrhea…

Read More Rapid diagnostic for gonorrhea won $19 million federal prize competition to combat antibiotic resistanceContinue

NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studies
Biotechnology | COVID-19 | Infectious Disease | Vaccine

NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studies

On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…

Read More NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studiesContinue

Page navigation

Previous PagePrevious 1 … 84 85 86 87 88 … 175 Next PageNext
  • Categories
  • Timeline
  • Aesthetics
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemistry
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search